PriceTargets.com logo

Vivani Medical - VANI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.00
  • Forecasted Upside: 610.95%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.98 As of 03/24/2023 01:00 AM ET
▼ -0.03 (-2.96%)

This chart shows the closing price for VANI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Vivani Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VANI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VANI

Analyst Price Target is $7.00
▲ +610.95% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Vivani Medical in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 610.95% upside from the last price of $0.98.

This chart shows the closing price for VANI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Vivani Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/5/2022ThinkEquityInitiated CoverageBuy$7.00Low
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.51 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Vivani Medical logo
Vivani Medical, Inc. develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. The company was founded on May 22,2003 and is headquartered in Emeryville, CA.
Read More

Today's Range

Now: $0.98
Low: $0.95
High: $1.03

50 Day Range

MA: $1.14
Low: $0.93
High: $1.47

52 Week Range

Now: $0.98
Low: $0.82
High: $8.10

Volume

23,016 shs

Average Volume

39,017 shs

Market Capitalization

$12.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Vivani Medical?

The following Wall Street analysts have issued reports on Vivani Medical in the last year: ThinkEquity.
View the latest analyst ratings for VANI.

What is the current price target for Vivani Medical?

1 Wall Street analysts have set twelve-month price targets for Vivani Medical in the last year. Their average twelve-month price target is $7.00, suggesting a possible upside of 610.9%. ThinkEquity has the highest price target set, predicting VANI will reach $7.00 in the next twelve months. ThinkEquity has the lowest price target set, forecasting a price of $7.00 for Vivani Medical in the next year.
View the latest price targets for VANI.

What is the current consensus analyst rating for Vivani Medical?

Vivani Medical currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VANI will outperform the market and that investors should add to their positions of Vivani Medical.
View the latest ratings for VANI.

What other companies compete with Vivani Medical?

Other companies that are similar to Vivani Medical include ENDRA Life Sciences, electroCore, Soleno Therapeutics, Helius Medical Technologies and Nuwellis. Learn More about companies similar to Vivani Medical.

How do I contact Vivani Medical's investor relations team?

Vivani Medical's physical mailing address is 13170 TELFAIR AVE., SYLMAR CA, 91342. The company's listed phone number is (818) 833-5000 and its investor relations email address is [email protected] The official website for Vivani Medical is www.vivani.com. Learn More about contacing Vivani Medical investor relations.